HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Filamin-A regulates neutrophil uropod retraction through RhoA during chemotaxis.

Abstract
Filamin-A (FLNa) has been shown to be a key cross-linker of actin filaments in the leading edge of a motile melanoma cell line, however its role in neutrophils undergoing chemotaxis is unknown. Using a murine transgenic model in which FLNa is selectively deleted in granulocytes, we report that, while neutrophils lacking FLNa show normal polarization and pseudopod extension, they exhibit obvious defects in uropod retraction. This uropod retraction defect was found to be a direct result of reduced FLNa mediated activation of the small GTPase RhoA and myosin mediated actin contraction in the FLNa null cells. This results in a neutrophil recruitment defect in FLNa null mice. The compensatory increase in FLNb levels that was observed in the FLNa null neutrophils may be sufficient to compensate for the lack of FLNa at the leading edge allowing for normal polarization, however this compensation is unable to regulate RhoA activated tail retraction at the rear of the cell.
AuthorsChunxiang Sun, Carol Forster, Fumihiko Nakamura, Michael Glogauer
JournalPloS one (PLoS One) Vol. 8 Issue 10 Pg. e79009 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24205360 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemotactic Factors
  • Filamins
  • FlnA protein, mouse
  • Myosins
  • rhoA GTP-Binding Protein
Topics
  • Animals
  • Cell Polarity
  • Chemotactic Factors (pharmacology)
  • Chemotaxis
  • Filamins (genetics, metabolism, physiology)
  • Genotype
  • Mice, Transgenic
  • Myosins (metabolism)
  • Neutrophils (drug effects, metabolism)
  • rhoA GTP-Binding Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: